Gilpin Wealth Management’s Vir Biotechnology VIR Stock Holding History

Gilpin Wealth Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$135	Sell	12 -5	-29%	-$50	﹤0.01%	1239
2026 Q2	$174	Sell	17 -2	-11%	-$19	﹤0.01%	943
2026 Q1	$171	Buy	19 +15	+375%	+$120	﹤0.01%	884
2025 Q4	$25	Buy	+4	New	+$24	﹤0.01%	969

Other funds holding VIR

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Gilpin Wealth Management's VIR Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Vir Biotechnology (VIR) stake by 29% in Q3 2026, selling an estimated $50 and leaving 12 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Gilpin Wealth Management first reported a position in VIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $174 in Q2 2026. 6 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

Gilpin Wealth Management held 12 shares of Vir Biotechnology worth $135 as of Q3 2026.
Gilpin Wealth Management sold 5 Vir Biotechnology shares in Q3 2026, an estimated $50.
Vir Biotechnology made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1239 holding.
Gilpin Wealth Management first reported a position in Vir Biotechnology in Q4 2025 and has held it in 4 quarters since.
Gilpin Wealth Management's Vir Biotechnology position peaked at $174 in Q2 2026.
6 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.